Heather Raymon - 15 May 2025 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role: SVP, Research and Development
Signature: /s/ Neha Krishnamohan, Attorney-in-Fact
Issuer symbol: ARTV
Transactions as of: 15 May 2025
Net transactions value: -$6,094
Form type: 4
Filing time: 18 Aug 2025, 20:15:11 UTC
Previous filing: 28 Feb 2025
Next filing: 17 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Raymon Heather	SVP, Research and Development	C/O ARTIVA BIOTHERAPEUTICS, INC., 5505 MOREHOUSE DRIVE, SUITE 100, SAN DIEGO	/s/ Neha Krishnamohan, Attorney-in-Fact	18 Aug 2025	0002028466

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARTV	Common Stock	Tax liability	$1,587	-745	-1.7%	$2.13	42,605	15 May 2025	Direct	F1
transaction	ARTV	Common Stock	Tax liability	$4,507	-1,639	-3.8%	$2.75	40,966	15 Aug 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.